CEPHALON FINLAND A/S: Financial statements 2025
CVR: 29245037
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CEPHALON FINLAND A/S (CVR 29245037) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. That is an increase of 78.3% compared with the year before. Equity in the 2025 report amounted to DKK 7,193,391. The solvency ratio was 55.4%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 7,078,554
- Profit/Loss
- DKK 2,059,375
- Equity
- DKK 7,193,391
- Total Assets
- DKK 12,983,483
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 7.1M | 2.1M | 7.2M | 5 |
| 2024 | - | 4M | 297K | 5.4M | 5 |
| 2023 | - | 4.2M | 521K | 5.1M | 5 |
| 2022 | - | 7M | 2.2M | 6.9M | 5 |
| 2021 | - | 5.8M | 1.3M | 6M | 6 |
Official annual report
How creditworthy is CEPHALON FINLAND A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CEPHALON FINLAND A/S has published its annual report for 2024. Gross profit came to DKK 3,970,317, and the net result was DKK 296,806.
About CEPHALON FINLAND A/S
CEPHALON FINLAND A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Rolf Nejsum and Vesa Antero Toropainen. The company is owned by Scanmed AS Norway. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. Equity in the 2025 report amounted to DKK 7,193,391.
